Comparing the effectiveness and safety of osteoporosis medications
Comparative Effectiveness and Safety of Osteoporosis Drug Therapies
This study is looking at how different osteoporosis medications can help prevent fractures in older adults and wants to hear from patients about their experiences to better understand the long-term safety and effectiveness of these treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10909902 on NIH RePORTER |
What this research studies
This research investigates how different osteoporosis drug therapies affect the risk of fractures in older adults. It aims to understand the long-term safety and effectiveness of these medications, particularly focusing on rare side effects that may occur with their use. By analyzing data from large randomized controlled trials, the study seeks to provide clearer guidance on the best treatment strategies for preventing osteoporotic fractures. Patients may be asked to participate in discussions about their experiences with these medications to help inform the research.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults, particularly those aged 65 and over, who are at risk of osteoporotic fractures.
Not a fit: Patients who are not at risk for osteoporosis or those who are already receiving effective treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies that reduce the risk of fractures and enhance the safety of osteoporosis medications for patients.
How similar studies have performed: Previous research has shown that osteoporosis drug therapies can significantly reduce fracture risk, but this study aims to explore new strategies that have not been fully tested yet.
Where this research is happening
Rochester, United States
- Mayo Clinic Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Brito Campana, Juan P — Mayo Clinic Rochester
- Study coordinator: Brito Campana, Juan P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.